Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 07 06 2019
revised: 19 08 2019
accepted: 20 08 2019
pubmed: 25 8 2019
medline: 21 7 2020
entrez: 25 8 2019
Statut: ppublish

Résumé

Non-competitive N-methyl-d-aspartate receptor antagonists mimic schizophrenia symptoms and produce immediate and persistent antidepressant effects. We investigated the effects of ketamine and phencyclidine (PCP) on thalamo-cortical network activity in awake, freely-moving male Wistar rats to gain new insight into the neuronal populations and brain circuits involved in the effects of NMDA-R antagonists. Single unit and local field potential (LFP) recordings were conducted in mediodorsal/centromedial thalamus and in medial prefrontal cortex (mPFC) using microelectrode arrays. Ketamine and PCP moderately increased the discharge rates of principal neurons in both areas while not attenuating the discharge of mPFC GABAergic interneurons. They also strongly affected LFP activity, reducing beta power and increasing that of gamma and high-frequency oscillation bands. These effects were short-lasting following the rapid pharmacokinetic profile of the drugs, and consequently were not present at 24 h after ketamine administration. The temporal profile of both drugs was remarkably different, with ketamine effects peaking earlier than PCP effects. Although this study is compatible with the glutamate hypothesis for fast-acting antidepressant action, it does not support a local disinhibition mechanism as the source for the increased pyramidal neuron activity in mPFC. The short-lasting increase in thalamo-cortical activity is likely associated with the rapid psychotomimetic action of both agents but could also be part of a cascade of events ultimately leading to the persistent antidepressant effects of ketamine. Changes in spectral contents of high-frequency bands by the drugs show potential as translational biomarkers for target engagement of NMDA-R modulators.

Identifiants

pubmed: 31445017
pii: S0028-3908(19)30304-1
doi: 10.1016/j.neuropharm.2019.107745
pii:
doi:

Substances chimiques

Excitatory Amino Acid Antagonists 0
Receptors, N-Methyl-D-Aspartate 0
Ketamine 690G0D6V8H
Phencyclidine J1DOI7UV76

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107745

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Maria Amat-Foraster (M)

H. Lundbeck A/S, Translational Biology, Valby, Denmark; University of Copenhagen, Faculty of Health and Medical Sciences, Department of Drug Design and Pharmacology, Copenhagen, Denmark; Institut d'Investigacions Biomèdiques de Barcelona IIBB-CSIC, Department of Neurochemistry and Neuropharmacology, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain. Electronic address: maaf@lundbeck.com.

Pau Celada (P)

Institut d'Investigacions Biomèdiques de Barcelona IIBB-CSIC, Department of Neurochemistry and Neuropharmacology, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain. Electronic address: pau.celada@iibb.csic.es.

Ulrike Richter (U)

H. Lundbeck A/S, Translational Biology, Valby, Denmark; Lund University, Department of Experimental Medical Science, Lund, Sweden. Electronic address: uric@lundbeck.com.

Anders A Jensen (AA)

University of Copenhagen, Faculty of Health and Medical Sciences, Department of Drug Design and Pharmacology, Copenhagen, Denmark. Electronic address: aaj@sund.ku.dk.

Niels Plath (N)

H. Lundbeck A/S, Translational Biology, Valby, Denmark. Electronic address: niep@lundbeck.com.

Francesc Artigas (F)

Institut d'Investigacions Biomèdiques de Barcelona IIBB-CSIC, Department of Neurochemistry and Neuropharmacology, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain. Electronic address: francesc.artigas@iibb.csic.es.

Kjartan F Herrik (KF)

H. Lundbeck A/S, Translational Biology, Valby, Denmark. Electronic address: kfh@lundbeck.com.

Articles similaires

Humans Ketamine Propofol Pulmonary Atelectasis Female
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH